天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> Vascular Health and Risk Management >>article

Vascular Health and Risk Management

IF: 2.6
Download PDF

Update on the use of trandolapril in the management of cardiovascular disorders.

Published:1 January 2008 DOI: 10.2147/vhrm.s3467 PMID: 19337528
Ariel Diaz, Anique Ducharme

Abstract

Trandolapril is a well known angiotensin converting enzyme (ACE) inhibitor with many cardiovascular (CV) indications. The objectives of this article are to review the pharmacokinetics and pharmacodynamics properties of trandolapril and to focus on its clinical relevance in cardiovascular medicine. Various populations have been studied in large clinical trials including patients with congestive heart failure (CHF) after an acute myocardial infarction (AMI), diabetics, patients with hypertension (HTN), stable coronary artery disease (CAD) and prevention of proteinuria. Long-term treatment with trandolapril in patients with reduced left ventricular function soon after AMI significantly reduced the risk of overall mortality, mortality from CV causes, sudden death, and the development of severe CHF. Treatment with trandolapril after AMI complicated by left ventricular dysfunction appears to be of considerable importance in patients with diabetes mellitus by saving lives and substantially reducing the risk of progression to severe CHF as well. Moreover, trandolapril reduces progression to proteinuria in high-risk patients. Some of the advantages of trandolapril over other ACE inhibitors are the wide spectrum of patient populations studied, the well established dosage and its proven trough-to-peak effect ratios permitting a safe once-a-day administration.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Trandolapril 87679-37-6 C24H34N2O5 214 suppliers $70.00-$1593.90

Similar articles

IF:13

Dutasteride: a review of its use in the management of prostate disorders.

Drugs Susan J Keam, Lesley J Scott,etc Published: 1 January 2008
IF:13

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Drugs Risto S Cvetkovic, Karen L Goa,etc Published: 1 January 2003
IF:13

Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.

Drugs Caroline M Perry, Lesley J Scott,etc Published: 1 January 2004